Tividenofusp Alfa: First Approval

Molecular Diagnosis and Therapy · Published 2026-06-18 · DOI 10.1007/s40291-026-00859-0

Authors (1)

Matt Shirley

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Shirley, M. (2026). Tividenofusp Alfa: First Approval. Molecular Diagnosis and Therapy. https://doi.org/10.1007/s40291-026-00859-0

Related articles

• Clinical, Genetic, Morphological and Functional Correlations in a Large Series of Patients with Primary Ciliary Dyskinesia: A Heterogeneous Disease with a Controversial Diagnosis · Molecular Diagnosis and Therapy · 2025 · Same journal
• Gastric Cancer Treatment New Chapter: Organoid Models Leading Personalized Medicine · Molecular Diagnosis and Therapy · 2025 · Same journal
• Advancing Medulloblastoma Treatment: Molecular Mechanisms, Drug Repurposing, and Precision Therapies · Molecular Diagnosis and Therapy · 2025 · Same journal
• Development of a Nomogram to Predict Therapeutic Resistance in Metastatic Melanoma Using Longitudinal ctDNA Kinetics · Molecular Diagnosis and Therapy · 2026 · Same journal
• The Future of Chemogenetics for the Treatment of Spasticity · Molecular Diagnosis and Therapy · 2025 · Same journal
• TROP2-Targeted Therapeutics in Development to Treat Gastrointestinal Tumors · Molecular Diagnosis and Therapy · 2026 · Same journal
• Co-encapsulation in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as an Emerging Therapeutic Strategy · Molecular Diagnosis and Therapy · 2026 · Same journal
• Marnetegragene Autotemcel: First Approval · Molecular Diagnosis and Therapy · 2026 · Same journal
• From PIK3CA Mutations to Rational PI3K Inhibition for the Treatment of Colorectal Cancer · Molecular Diagnosis and Therapy · 2025 · Same journal
• Beyond Binary FISH Results: Targeted NGS Provides Deeper Characterization of MYC and Broader Genomic Alterations in DLBCL · Molecular Diagnosis and Therapy · 2026 · Same journal